Drug intelligence / Profile preview

pelargonium sidoides

Development stage
Unknown
Lead developer
Schwabe
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Pelargonium sidoides is a **medicinal herb native to southern Africa**, widely used in traditional medicine, primarily as a root extract, for its therapeutic potential in treating **respiratory tract infections** (such as acute bronchitis, common cold, rhinosinusitis, COPD) as well as gastrointestinal ailments like dysentery and diarrhea[1][3][5]. Modern phytopharmaceutical preparations, most notably EPs 7630, have undergone clinical trials demonstrating efficacy in reducing symptom severity and duration in acute bronchitis and other respiratory conditions[1][2][3][5]. The extract's main active compounds include **polyphenols (catechin), highly oxygenated coumarins (e.g., umckalin), proanthocyanidins, flavonoids, and gallic acid derivatives**[1][3][5]. The mechanism of action is believed to be primarily **immunomodulatory** (stimulation of natural killer cells, interferon-beta, and enhancement of phagocyte function), as well as **antiviral** and **antiadhesive** effects (inhibition of microbial/viral binding to host cells and suppression of neuraminidase enzyme activity)[1][3][5]. There is minimal direct antimicrobial activity, but the extract promotes host defense against pathogens[1][3].

Brand names
EPs 7630EPs7630EPs-7630UmckaloaboPelaPower extractPelaPowerPELAFORCEZucolKalobaRabassaminUmckaUmckaboUmckaloaba
Other names
African geraniumKalwerbossie
02

Targets

Mpro (3C-like proteinase of SARS-CoV-2)LTF (Lactoferrin)Neuraminidase

Beyond the preview

Go deeper on pelargonium sidoides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pelargonium sidoides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call